4
Changes in Ownership
Arcutis Biotherapeutics, Inc. Filed Acc 0001567619-21-007700
President and CEO sold 1,750 shares at $29.93 ($52,378)
From the SEC's structured data for this filing
Trades in this filing
Watanabe Todd Franklin · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-04-05 | Sale : show line 1 in the form | −1,750 | $29.93 | $52,378 | 595,416 | D |
| Open-market sales · 1,750 sh · avg $29.93 · $52,378 | ||||||
Loading xslF345X03/doc1.xml…